Neoadjuvant FOLFIRINOX treatment for borderline resectable pancreatic ductal adenocarcinoma: The pathological implications. (April 2016) - Graham, J.; Jamieson, N.; Duthie, F.; Palani Velu, L.; Ali, C.; Maclaren, V.; Grose, D.; Mcintosh, D.; Mckay, C.J.; Dickson, E.; Carter, R.